ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastro Esophageal Reflux Disease (GERD) Drug Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-2O8859
Home | Market Reports | Health| Health Conditions
Global Gastro Esophageal Reflux Disease GERD Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Global Gastro Esophageal Reflux Disease (GERD) Drug Market Research Report 2025

Code: QYRE-Auto-2O8859
Report
January 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Novartis
GlaxoSmithKline PLC
Merck
Medtronic Inc
The Kroger Co.
Aros Pharma
Astrazeneca plc
Addex Therapeutics
Takeda Pharmaceutical Company Limited

Gastro Esophageal Reflux Disease (GERD) Drug Market Size

The global market for Gastro Esophageal Reflux Disease (GERD) Drug was valued at US$ 971 million in the year 2024 and is projected to reach a revised size of US$ 1559 million by 2031, growing at a CAGR of 7.1% during the forecast period.

Gastro Esophageal Reflux Disease (GERD) Drug Market

Gastro Esophageal Reflux Disease (GERD) Drug Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastro Esophageal Reflux Disease (GERD) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastro Esophageal Reflux Disease (GERD) Drug.
The Gastro Esophageal Reflux Disease (GERD) Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastro Esophageal Reflux Disease (GERD) Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastro Esophageal Reflux Disease (GERD) Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gastro Esophageal Reflux Disease (GERD) Drug Market Report

Report Metric Details
Report Name Gastro Esophageal Reflux Disease (GERD) Drug Market
Accounted market size in year US$ 971 million
Forecasted market size in 2031 US$ 1559 million
CAGR 7.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Medical Center
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Novartis AG, GlaxoSmithKline, Merck, Medtronic, The Kroger Co., Aros Pharma, AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gastro Esophageal Reflux Disease (GERD) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gastro Esophageal Reflux Disease (GERD) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Gastro Esophageal Reflux Disease (GERD) Drug Market growing?

Ans: The Gastro Esophageal Reflux Disease (GERD) Drug Market witnessing a CAGR of 7.1% during the forecast period 2025-2031.

What is the Gastro Esophageal Reflux Disease (GERD) Drug Market size in 2031?

Ans: The Gastro Esophageal Reflux Disease (GERD) Drug Market size in 2031 will be US$ 1559 million.

Who are the main players in the Gastro Esophageal Reflux Disease (GERD) Drug Market report?

Ans: The main players in the Gastro Esophageal Reflux Disease (GERD) Drug Market are Pfizer, Novartis AG, GlaxoSmithKline, Merck, Medtronic, The Kroger Co., Aros Pharma, AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited

What are the Application segmentation covered in the Gastro Esophageal Reflux Disease (GERD) Drug Market report?

Ans: The Applications covered in the Gastro Esophageal Reflux Disease (GERD) Drug Market report are Hospital, Clinic, Medical Center, Others

What are the Type segmentation covered in the Gastro Esophageal Reflux Disease (GERD) Drug Market report?

Ans: The Types covered in the Gastro Esophageal Reflux Disease (GERD) Drug Market report are H2 Receptor Antagonist, Proton Pump Inhibitor (PPi), Antacids

Recommended Reports

Digestive Disease Markets

Pharmaceutical Drug Markets

Medical Device & Diagnosis

1 Gastro Esophageal Reflux Disease (GERD) Drug Market Overview
1.1 Product Definition
1.2 Gastro Esophageal Reflux Disease (GERD) Drug by Type
1.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 H2 Receptor Antagonist
1.2.3 Proton Pump Inhibitor (PPi)
1.2.4 Antacids
1.3 Gastro Esophageal Reflux Disease (GERD) Drug by Application
1.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Others
1.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Estimates and Forecasts
1.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue 2020-2031
1.4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales 2020-2031
1.4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gastro Esophageal Reflux Disease (GERD) Drug Market Competition by Manufacturers
2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gastro Esophageal Reflux Disease (GERD) Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug, Product Type & Application
2.7 Global Key Manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug, Date of Enter into This Industry
2.8 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Competitive Situation and Trends
2.8.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gastro Esophageal Reflux Disease (GERD) Drug Players Market Share by Revenue
2.8.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Scenario by Region
3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region: 2020-2031
3.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region: 2020-2025
3.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region: 2026-2031
3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region: 2020-2031
3.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region: 2020-2025
3.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region: 2026-2031
3.4 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
3.4.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2020-2031)
3.4.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
3.5.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2020-2031)
3.5.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
3.7.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2020-2031)
3.7.3 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2020-2031)
4.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2020-2025)
4.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2026-2031)
4.1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2020-2031)
4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2020-2031)
4.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2020-2025)
4.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2026-2031)
4.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2020-2031)
4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2020-2031)
5.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2020-2025)
5.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2026-2031)
5.1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2020-2031)
5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2020-2031)
5.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2020-2025)
5.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2026-2031)
5.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2020-2031)
5.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Company Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Company Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 The Kroger Co.
6.6.1 The Kroger Co. Company Information
6.6.2 The Kroger Co. Description and Business Overview
6.6.3 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
6.6.5 The Kroger Co. Recent Developments/Updates
6.7 Aros Pharma
6.7.1 Aros Pharma Company Information
6.7.2 Aros Pharma Description and Business Overview
6.7.3 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
6.7.5 Aros Pharma Recent Developments/Updates
6.8 AstraZeneca, Plc.
6.8.1 AstraZeneca, Plc. Company Information
6.8.2 AstraZeneca, Plc. Description and Business Overview
6.8.3 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
6.8.5 AstraZeneca, Plc. Recent Developments/Updates
6.9 Addex Therapeutics
6.9.1 Addex Therapeutics Company Information
6.9.2 Addex Therapeutics Description and Business Overview
6.9.3 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
6.9.5 Addex Therapeutics Recent Developments/Updates
6.10 Takeda Pharmaceutical Company Limited
6.10.1 Takeda Pharmaceutical Company Limited Company Information
6.10.2 Takeda Pharmaceutical Company Limited Description and Business Overview
6.10.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
6.10.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Chain Analysis
7.2 Gastro Esophageal Reflux Disease (GERD) Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastro Esophageal Reflux Disease (GERD) Drug Production Mode & Process Analysis
7.4 Gastro Esophageal Reflux Disease (GERD) Drug Sales and Marketing
7.4.1 Gastro Esophageal Reflux Disease (GERD) Drug Sales Channels
7.4.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors
7.5 Gastro Esophageal Reflux Disease (GERD) Drug Customer Analysis
8 Gastro Esophageal Reflux Disease (GERD) Drug Market Dynamics
8.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Trends
8.2 Gastro Esophageal Reflux Disease (GERD) Drug Market Drivers
8.3 Gastro Esophageal Reflux Disease (GERD) Drug Market Challenges
8.4 Gastro Esophageal Reflux Disease (GERD) Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Novartis
GlaxoSmithKline PLC
Merck
Medtronic Inc
The Kroger Co.
Aros Pharma
Astrazeneca plc
Addex Therapeutics
Takeda Pharmaceutical Company Limited
List of Tables
 Table 1. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gastro Esophageal Reflux Disease (GERD) Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gastro Esophageal Reflux Disease (GERD) Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gastro Esophageal Reflux Disease (GERD) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastro Esophageal Reflux Disease (GERD) Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Gastro Esophageal Reflux Disease (GERD) Drug Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Gastro Esophageal Reflux Disease (GERD) Drug Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Gastro Esophageal Reflux Disease (GERD) Drug Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Gastro Esophageal Reflux Disease (GERD) Drug Price (USD/Pcs) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Novartis AG Company Information
 Table 76. Novartis AG Description and Business Overview
 Table 77. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product
 Table 79. Novartis AG Recent Developments/Updates
 Table 80. GlaxoSmithKline Company Information
 Table 81. GlaxoSmithKline Description and Business Overview
 Table 82. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product
 Table 84. GlaxoSmithKline Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Medtronic Company Information
 Table 91. Medtronic Description and Business Overview
 Table 92. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product
 Table 94. Medtronic Recent Developments/Updates
 Table 95. The Kroger Co. Company Information
 Table 96. The Kroger Co. Description and Business Overview
 Table 97. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product
 Table 99. The Kroger Co. Recent Developments/Updates
 Table 100. Aros Pharma Company Information
 Table 101. Aros Pharma Description and Business Overview
 Table 102. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product
 Table 104. Aros Pharma Recent Developments/Updates
 Table 105. AstraZeneca, Plc. Company Information
 Table 106. AstraZeneca, Plc. Description and Business Overview
 Table 107. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product
 Table 109. AstraZeneca, Plc. Recent Developments/Updates
 Table 110. Addex Therapeutics Company Information
 Table 111. Addex Therapeutics Description and Business Overview
 Table 112. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product
 Table 114. Addex Therapeutics Recent Developments/Updates
 Table 115. Takeda Pharmaceutical Company Limited Company Information
 Table 116. Takeda Pharmaceutical Company Limited Description and Business Overview
 Table 117. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product
 Table 119. Takeda Pharmaceutical Company Limited Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Gastro Esophageal Reflux Disease (GERD) Drug Distributors List
 Table 123. Gastro Esophageal Reflux Disease (GERD) Drug Customers List
 Table 124. Gastro Esophageal Reflux Disease (GERD) Drug Market Trends
 Table 125. Gastro Esophageal Reflux Disease (GERD) Drug Market Drivers
 Table 126. Gastro Esophageal Reflux Disease (GERD) Drug Market Challenges
 Table 127. Gastro Esophageal Reflux Disease (GERD) Drug Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gastro Esophageal Reflux Disease (GERD) Drug
 Figure 2. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Type: 2024 & 2031
 Figure 4. H2 Receptor Antagonist Product Picture
 Figure 5. Proton Pump Inhibitor (PPi) Product Picture
 Figure 6. Antacids Product Picture
 Figure 7. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Medical Center
 Figure 12. Others
 Figure 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (2020-2031) & (K Pcs)
 Figure 16. Global Gastro Esophageal Reflux Disease (GERD) Drug Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Gastro Esophageal Reflux Disease (GERD) Drug Report Years Considered
 Figure 18. Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Manufacturers in 2024
 Figure 19. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Gastro Esophageal Reflux Disease (GERD) Drug Players: Market Share by Revenue in Gastro Esophageal Reflux Disease (GERD) Drug in 2024
 Figure 21. Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2020-2031)
 Figure 24. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2020-2031)
 Figure 28. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2020-2031)
 Figure 36. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Gastro Esophageal Reflux Disease (GERD) Drug by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Gastro Esophageal Reflux Disease (GERD) Drug by Type (2020-2031)
 Figure 58. Global Gastro Esophageal Reflux Disease (GERD) Drug Price (USD/Pcs) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Gastro Esophageal Reflux Disease (GERD) Drug by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Gastro Esophageal Reflux Disease (GERD) Drug by Application (2020-2031)
 Figure 61. Global Gastro Esophageal Reflux Disease (GERD) Drug Price (USD/Pcs) by Application (2020-2031)
 Figure 62. Gastro Esophageal Reflux Disease (GERD) Drug Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Gastroesophageal Reflux Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Proton Pump Inhibitor Drug Market Research Report 2025
Gastroesophageal Reflux Disease GERD Diagnosis Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Global Cardiovascular Disease Nursing Drugs Market Research Report 2025
Global Pharmaceutical Validation Services Market Research Report 2025
Global Gynecological Cancers Drug Market Research Report 2025
Global CGT Drugs Market Research Report 2025
Global Cholesterol Lowering Drugs Market Research Report 2024
Global Weekly Pill Organizer Market Research Report 2025
Global Treatment Planning Software Market Research Report 2025
Global Pharmerging Market Research Report 2025
Global Drug Safety and Pharmacovigilance Service Market Research Report 2025
Global Diagnostic Guidewire Market Research Report 2024
Global Pill Organizer with Timer Reminder Market Research Report 2025
Global Combination Therapy Drug Market Research Report 2025
Global Pharmaceutical Asset Management Market Research Report 2025
Global Peptic Ulcers Treatment Market Research Report 2024
Global Pharmaceutical Filter Aid Market Research Report 2025
Global AI Image assisted Diagnosis Software Market Research Report 2025

RELATED REPORTS

Global Inhaled Treatment for Asthma and COPD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Y19888
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Bladder Cancer Therapeutics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38Z13489
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Allergy Skin Test Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12K7064
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Urinary Slings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26L5971
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions